Precision for Value’s Jeremy Schafer is featured in Managed Healthcare Executive, offering expert insight on how rebates contribute to patient savings as well as greater transparency among stakeholders. (more…)
Andrew Cournoyer, vice president at Precision for Value, offers an initial reaction to CMS’s new flexibility on offering benefits and controlling costs, which are expected to grow the Medicare Advantage program. (more…)
Precision for Medicine’s Judi Smith and Karen Richards highlight key takeaways from the FDA’s Cardiac Troponin Assays workshop. (more…)
Payer, Health System and Channel influences driving utilization patterns of specialty products in Local Markets will be the focus of Larry Blandford and Ashwin Athri’s presentation at sPCMA March 5 in Orlando, Florida. Identifying such influences, they note, can help guide interventions and go to market strategies.
Precision Value & Health president Dan Renick speaks with American Healthcare Leader on the evolution of the healthcare industry and the challenges manufacturers face today. (more…)
We are proud to be recognized as one of the Top 20 Bioinformatics Solution Providers by respected technology trends magazine CIO Applications. (more…)
Jeremy Schafer, director of Precision’s Payer Access Solutions, details the challenges facing gene therapy reimbursement and offers potential solutions. (more…)
Jeremy Schafer, director of Precision’s Payer Access Solutions, shares his thoughts on drug pricing, M&A activity, 340B changes, and other things top-of-mind for 2018. (more…)
ADDITION OF NEW YORK-BASED FIRM COMPLEMENTS AND STRATEGICALLY EXPANDS PRECISION’S EXISTING GLOBAL MARKET ACCESS EXPERTISE AND CAPABILITIES
New York, NY – Tuesday, January 30, 2018 – Precision Value & Health today announced it is acquiring Insight Strategy Advisors (ISA), a New York-based leading market access consultancy supporting value demonstration, pricing, reimbursement, and distribution for biopharmaceutical companies. ISA will become part of Precision Xtract, the global market access consultancy within Precision Value & Health.
Jeremy Schafer, SVP, Director of Precision’s Payer Access Solutions, offers advice to healthcare executives on helping patients get access to crucial new cancer drugs. (more…)